We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$7.73B
1-Year Est. Return
14.94%
This Fund
S&P 500
This Quarter
Est. Return
+5.66%
1 Year Est. Return
+14.94%
3 Year Est. Return
+71.58%
5 Year Est. Return
+102.98%
10 Year Est. Return
+355.22%
AUM
$3.75B
AUM Growth
-$52.5M
(-1.4%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
360
New
28
Increased
96
Reduced
143
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EACQ
Easterly Acquisition Corp
EACQ
|
+$9.98M |
| 2 |
AGN
Allergan plc
AGN
|
+$4.37M |
| 3 |
PX
Praxair Inc
PX
|
+$3.81M |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.93M |
| 5 |
First Trust Senior Loan Fund ETF
FTSL
|
+$2.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$43M |
| 2 |
Chubb
CB
|
+$38.8M |
| 3 |
Abbott
ABT
|
+$33.4M |
| 4 |
Aflac
AFL
|
+$29.1M |
| 5 |
AT&T
T
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.17% |
| 2 | Technology | 16.95% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.36% |
Similar funds
SIAU
WRCM
BFM
IMCOOI
MAM
EHC
PA
PGFC
Welch & Forbes's Q4 2017 Portfolio in Review
As of Q4 2017, Welch & Forbes held 360 positions worth $3.75B, down 1.4% from $3.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Welch & Forbes withdrew a net $224M in Q4 2017, closing 22 positions and reducing 143 holdings. Its most notable exit was AbbVie, an estimated $43M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 20% a quarter earlier, followed by Technology and Financials.
Against the trend, Welch & Forbes opened a new position in Easterly Acquisition Corp worth $10M.
- Welch & Forbes's largest Q4 2017 buy was Easterly Acquisition Corp: 994,036 shares worth $10M.
- Welch & Forbes added most to Praxair Inc in Q4 2017, an estimated $3.81M increase.
- Welch & Forbes's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $8.07M.
- Welch & Forbes fully exited AbbVie in Q4 2017, selling an estimated $43M.
- Welch & Forbes's ten largest holdings make up 23% of its $3.75B portfolio in Q4 2017.
- Welch & Forbes opened 28 new positions and closed 22 in Q4 2017.
- Welch & Forbes's portfolio value fell 1.4% quarter-over-quarter to $3.75B.
Based on Welch & Forbes's 13F filing for Q4 2017, filed 26 Jan 2018.